en.Wedoany.com Reported - Neko Health has introduced body composition analysis and wearable device integration into its health scanning service, marking the largest feature update since the product's launch.

The upgraded scanning process utilizes data collected by Neko Health's self-developed imaging equipment to quantitatively assess fat stored around internal organs, known as visceral fat. The company states that this type of fat is associated with metabolic diseases, insulin resistance, and fatty liver disease, and cannot be detected through Body Mass Index (BMI) or routine health checks. The entire assessment process does not use X-ray radiation, aiming to provide data to support discussions between members and Neko clinicians regarding metabolic health.

Neko Health has begun gradually rolling out these new features at its clinics. Members can access new metrics such as visceral fat and body fat percentage, and can directly integrate personal health data from wearable devices into the scanning process. For members with scheduled scans, the Neko Health App (iOS version) can connect to Apple Health data, importing metrics such as step count, sleep patterns, and heart rate variability for review as part of the health scan. The company believes this provides clinicians with more contextual information to offer personalized guidance; data tracked during repeat visits also helps explain year-over-year changes in a member's health status.

Hjalmar Nilsonne, founder and CEO of Neko Health, stated: "Every scan should be more valuable than the last; every visit should tell members something they couldn't have known otherwise; every year should bring capabilities that were not possible the year before. We are fundamentally redesigning the entire system." The company develops its own technology, software, and clinical protocols, and currently offers one-hour full-body health scans at locations in Stockholm, London, Manchester, and Birmingham.

In January 2025, Neko Health completed a $260 million Series B funding round, with funds to be used for further research and development, as well as to promote its medical scanners into the U.S. and European markets.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com